ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

1.83
0.12
(7.02%)
Closed January 26 3:00PM
1.79
-0.04
(-2.19%)
After Hours: 6:30PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.79
Bid
1.79
Ask
1.80
Volume
314,041
1.70 Day's Range 1.93
1.41 52 Week Range 18.7192
Market Cap
Previous Close
1.71
Open
1.70
Last Trade
19
@
1.79
Last Trade Time
Financial Volume
US$ 566,723
VWAP
1.8046
Average Volume (3m)
1,595,330
Shares Outstanding
3,007,431
Dividend Yield
-
PE Ratio
-0.75
Earnings Per Share (EPS)
-2.47
Revenue
19k
Net Profit
-7.44M

About Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector
Pharmaceutical Preparations
Industry
Management Consulting Svcs
Headquarters
Wilmington, Delaware, USA
Founded
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.71. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.41 to US$ 18.7192.

Sonnet BioTherapeutics currently has 3,007,431 shares outstanding. The market capitalization of Sonnet BioTherapeutics is US$5.14 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.75.

SONN Latest News

Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Live webcast on Wednesday, January 29th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the โ€œCompanyโ€ or โ€œSonnetโ€) (NASDAQ: SONN), a...

Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelisยฎ...

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the โ€œCompanyโ€ or โ€œSonnetโ€) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2415.48387096771.552.051.445246491.84917045CS
40.2818.54304635761.512.521.443326491.77232918CS
12-2.72-60.3104212864.5110.021.4115953302.48109034CS
26-5.0988-74.01579375226.888810.021.417661742.81761629CS
52-9.09-83.547794117610.8818.71921.414224103.77456914CS
156-770.1812-99.7681260648771.97121649.40161.411918035553.03042245CS
260-15324.29-99.988320562115326.0839916.81.4122948152544.85975759CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?
The current share price of Sonnet BioTherapeutics is US$ 1.79
How many Sonnet BioTherapeutics shares are in issue?
Sonnet BioTherapeutics has 3,007,431 shares in issue
What is the market cap of Sonnet BioTherapeutics?
The market capitalisation of Sonnet BioTherapeutics is USD 5.14M
What is the 1 year trading range for Sonnet BioTherapeutics share price?
Sonnet BioTherapeutics has traded in the range of US$ 1.41 to US$ 18.7192 during the past year
What is the PE ratio of Sonnet BioTherapeutics?
The price to earnings ratio of Sonnet BioTherapeutics is -0.75
What is the cash to sales ratio of Sonnet BioTherapeutics?
The cash to sales ratio of Sonnet BioTherapeutics is 293.65
What is the reporting currency for Sonnet BioTherapeutics?
Sonnet BioTherapeutics reports financial results in USD
What is the latest annual turnover for Sonnet BioTherapeutics?
The latest annual turnover of Sonnet BioTherapeutics is USD 19k
What is the latest annual profit for Sonnet BioTherapeutics?
The latest annual profit of Sonnet BioTherapeutics is USD -7.44M
What is the registered address of Sonnet BioTherapeutics?
The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Sonnet BioTherapeutics website address?
The website address for Sonnet BioTherapeutics is www.sonnetbio.com
Which industry sector does Sonnet BioTherapeutics operate in?
Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

SONN Discussion

View Posts
tw0122 tw0122 2 months ago
Cash out time 5.45 + 150%
👍 1
LowFloatLopes LowFloatLopes 2 months ago
I'm at $2.50 out at $4.50 in less than 8 mins lol 
๐Ÿ‘๏ธ0
tw0122 tw0122 2 months ago
Don't stay in long this one hardly ever stays up high long 3.49 +'80%
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 months ago
SONN, 10Q due DEC 13
๐Ÿ‘๏ธ0
tw0122 tw0122 3 months ago
Reverse split was September 
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 3 months ago
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
๐Ÿ‘๏ธ0
Tiger Money Tiger Money 3 months ago
What is going on here?  Reverse?  Where is the float on this train wreck now?
๐Ÿ‘๏ธ0
bigfart bigfart 3 months ago
So insiders can dump before the RS
๐Ÿ‘๏ธ0
tw0122 tw0122 3 months ago
Reverse split offering and now some news $8s
๐Ÿ‘๏ธ0
tw0122 tw0122 4 months ago
May the reverse split gods come soon. Keep an eye!
๐Ÿ‘๏ธ0
BooDog BooDog 4 months ago
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
๐Ÿ‘๏ธ0
Clemdane Clemdane 5 months ago
Big jump today!
๐Ÿ‘๏ธ0
Awl416 Awl416 5 months ago
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 5 months ago
SONN new 52=low
๐Ÿ‘๏ธ0
Clemdane Clemdane 5 months ago
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 7 months ago
SONN new 52 week low
๐Ÿ‘๏ธ0
BooDog BooDog 9 months ago
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
๐Ÿ‘๏ธ0
maq1214 maq1214 10 months ago
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad itโ€™s greening again !
๐Ÿ‘๏ธ0
81vette 81vette 10 months ago
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
๐Ÿ‘๏ธ0
81vette 81vette 10 months ago
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
๐Ÿ‘๏ธ0
maq1214 maq1214 10 months ago
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
๐Ÿ‘๏ธ0
81vette 81vette 10 months ago
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
๐Ÿ‘๏ธ0
81vette 81vette 10 months ago
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
๐Ÿ‘๏ธ0
81vette 81vette 10 months ago
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
๐Ÿ‘๏ธ0
BooDog BooDog 11 months ago
Riding free again.
๐Ÿ‘๏ธ0
Monksdream Monksdream 11 months ago
SONN under $2
๐Ÿ‘๏ธ0
crowin crowin 11 months ago
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
๐Ÿ‘๏ธ0
maq1214 maq1214 11 months ago
This should get exciting soon, crazy volume yesterday !
๐Ÿ‘๏ธ0
BooDog BooDog 12 months ago
IS it just greed or might this make good for another round trip? We'll see next week.
๐Ÿ‘๏ธ0
BooDog BooDog 1 year ago
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the โ€œCommitteeโ€) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the โ€œCompanyโ€) cancelled accrued but unpaid bonuses (the โ€œCancelled Bonusesโ€) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Companyโ€™s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Companyโ€™s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Companyโ€™s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0
BooDog BooDog 1 year ago
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
If the stock continues to make new lows on its way to a delisting to Cromwell Coulsonโ€™s stock market or a dissolution I will continue to record it
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
You worry about you ok?
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
You arenโ€™t getting any money back
Time to move on
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
Not an Urban Myth ..I've already checked. They have current D and O insurance.
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
Oh goddamn tell me another urban myth
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
You wouldnโ€™t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
๐Ÿ‘๏ธ0
valleybenedetto valleybenedetto 1 year ago
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
SONN new 52 week low
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock